Research graph
References from Early outcomes of the Octapro balloon-expandable transcatheter heart valve in an unrestricted cohort of patients with aortic valve stenosis: the MyPro registry. Local targets link to admitted publications; unresolved targets remain external evidence.
ESC/EACTS guidelines for the management of valvular heart disease
10.1093/eurheartj/ehaf194 · 2025 · External reference
Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis
10.1016/j.ijcard.2023.131701 · 2024 · External reference
Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in patients with bioprosthetic left side heart valves failure: 1-year follow-up from a multicenter experience
10.1016/j.ijcard.2023.01.017 · 2023 · External reference
Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis - a real-world Indian experience (the OCTACOR India study)
10.1016/j.carrev.2024.01.016 · 2024 · External reference
Balloon-expandable Myval Octacor versus self-expanding Evolut PRO/PRO+ and Acurate Neo2: short-term outcomes from propensity-matched analysis
2025 · External reference
Immediate and early outcomes following Myval Octacor transcatheter heart valve implantation for the treatment of patients with severe aortic valve stenosis: the OCTACOR-EU study
2025 · External reference
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
10.1016/s0140-6736(24)00821-3 · 2024 · External reference
1-year outcomes of novel balloon-expandable vs contemporary transcatheter heart valves in severe aortic stenosis: the LANDMARK trial
10.1016/j.jacc.2025.10.076 · 2026 · External reference
SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial
10.1016/s0140-6736(25)00106-0 · 2025 · External reference
Neocommissural/coronary alignment with a novel balloon expandable transcatheter aortic valve: first-in-human experience
10.1016/j.jcin.2023.07.012 · 2023 · External reference
Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus
10.1056/nejmoa2312573 · 2024 · External reference
Patient-tailored aortic valve replacement
10.3389/fcvm.2021.658016 · 2021 · External reference
Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research
10.1016/j.jacc.2021.02.038 · 2021 · External reference
ESC guidelines on cardiac pacing and cardiac resynchronization therapy
10.1093/eurheartj/ehab364 · 2021 · External reference
Assessing the novel myval balloon-expandable valve with the evolut valve: a propensity-matched study
10.3390/jcm12134213 · 2023 · External reference
Predictors and 5-year clinical outcomes of pacemaker after TAVR: analysis from the PARTNER 2 SAPIEN 3 registries
10.1016/j.jcin.2024.03.034 · 2024 · External reference
Anatomical and functional predictors of permanent pacemaker implantation after transcatheter aortic valve implantation
2025 · External reference
Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves
10.4244/eij-d-22-01030 · 2023 · External reference
